Literature DB >> 18423105

The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients.

Futoshi Anan1, Takayuki Masaki, Tetsu Iwao, Takeshi Eto, Tsuyoshi Shimomura, Yoshikazu Umeno, Nobuoki Eshima, Tetsunori Saikawa, Hironobu Yoshimatsu.   

Abstract

OBJECTIVE: The presence of white matter lesions (WML) is an important prognostic factor for the development of stroke. Microalbuminuria, which is associated with diabetes, has been flagged as a novel predictor for cerebrovascular events. This preliminary study was therefore designed to test the hypothesis that the presence of WML correlates with microalbuminuria and insulin resistance in patients with type 2 diabetic mellitus (DM) not receiving insulin treatment. PATIENTS AND METHODS: Based on brain magnetic resonance imaging (MRI) findings, 90 type 2 diabetic patients were divided into two groups: a WML-positive group (57+/-8 years, mean+/-SD, n=34) and a WML-negative group (57+/-6 years, n=56). The level of blood glucose was assessed by fasting plasma glucose (FPG), fasting immunoreactive insulin (F-IRI), homeostasis model assessment (HOMA) index, and hemoglobin A(1c) (HbA1c).
RESULTS: The body mass index was higher in the WML-positive group than in the WML-negative group (p<0.01). Plasma levels of triglycerides were higher while high-density lipoprotein cholesterol (HDL-C) was lower in the WML-positive group than in the WML-negative group (p<0.05 and p<0.0001, respectively). Fasting plasma glucose (p<0.005), insulin concentrations (p<0.0001), HOMA index (p<0.0001), and urinary albumin excretion (p<0.0001) levels were higher in the WML-positive group than in the WML-negative group. Multivariate logistic analysis revealed that WML was independently predicted by the microalbuminuria and insulin resistance (p<0.005, p<0.0005, respectively).
CONCLUSION: The results of this preliminary study indicate that the presence of WML was associated with the microalbuminuria and insulin resistance in these Japanese patients with type 2 DM; larger cohort studies are warranted to confirm these findings.

Entities:  

Mesh:

Year:  2008        PMID: 18423105     DOI: 10.1185/03007990802061818

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  8 in total

1.  Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.

Authors:  Mariana Murea; Fang-Chi Hsu; Amanda J Cox; Christina E Hugenschmidt; Jianzhao Xu; Jeremy N Adams; Laura M Raffield; Christopher T Whitlow; Joseph A Maldjian; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2015-02-26       Impact factor: 5.992

2.  Association Between White Matter Hyperintensities and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Cun-Sheng Wei; Cai-Yun Yan; Xiao-Rong Yu; Lin Wang; Rui Zhang; Jun-Ying Jiang; Qi Dai; Jun-Rong Li; Xue Mei Chen
Journal:  Front Med (Lausanne)       Date:  2022-05-03

3.  Brain MRI Volume Findings in Diabetic Adults With Albuminuria: The ACCORD-MIND Study.

Authors:  Joshua I Barzilay; Timothy M Morgan; Anne M Murray; R Nick Bryan; Jeff D Williamson; Adrian Schnall; Lenore J Launer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-11-19       Impact factor: 6.053

Review 4.  Cerebral small vessel disease and renal function: systematic review and meta-analysis.

Authors:  Stephen D J Makin; F A B Cook; Martin S Dennis; Joanna M Wardlaw
Journal:  Cerebrovasc Dis       Date:  2014-12-24       Impact factor: 2.762

5.  Causal Impact of Type 2 Diabetes Mellitus on Cerebral Small Vessel Disease: A Mendelian Randomization Analysis.

Authors:  Junfeng Liu; Loes Rutten-Jacobs; Ming Liu; Hugh S Markus; Matthew Traylor
Journal:  Stroke       Date:  2018-04-23       Impact factor: 7.914

6.  ApoA-I Mimetic Peptide Reduces Vascular and White Matter Damage After Stroke in Type-2 Diabetic Mice.

Authors:  Xiaohui Wang; Rongwen Li; Alex Zacharek; Julie Landschoot-Ward; Michael Chopp; Jieli Chen; Xu Cui
Journal:  Front Neurosci       Date:  2019-10-25       Impact factor: 4.677

Review 7.  The Mechanisms of Type 2 Diabetes-Related White Matter Intensities: A Review.

Authors:  Jing Sun; Baofeng Xu; Xuejiao Zhang; Zhidong He; Ziwei Liu; Rui Liu; Guangxian Nan
Journal:  Front Public Health       Date:  2020-11-17

8.  Post-Stroke Administration of L-4F Promotes Neurovascular and White Matter Remodeling in Type-2 Diabetic Stroke Mice.

Authors:  Min Zhou; Rongwen Li; Poornima Venkat; Yu Qian; Michael Chopp; Alex Zacharek; Julie Landschoot-Ward; Brianna Powell; Quan Jiang; Xu Cui
Journal:  Front Neurol       Date:  2022-04-28       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.